English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52640584    線上人數 :  945
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 266-275 / 1656 (共166頁)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-01T01:54:29Z Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation Huang T.-C.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-09-01T01:54:27Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:26Z OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:25Z Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy Lin Y.-C.; Wei L.-H.; Shun C.-T.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-09-01T01:54:23Z The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:22Z Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:19Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:17Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:12Z Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG

顯示項目 266-275 / 1656 (共166頁)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
每頁顯示[10|25|50]項目